- 英文名称
- Chaetocin
- 分子式
- C30H28N6O6S4
- 分子量
- 696.84
- 中文别名
- 毛蕊花素; 毛壳素A; 毛壳霉素; (3S,3′S,5AR,5′AR,10BR,10′BR,11AS,11′AS)-2,2′,3,3′,5A,5′A,6,6′-八氢-3,3′-双(羟甲基)-2,2′-二甲基[10B,10′B(11H,11′H)-双-3,11A-EPIDITHIO-11AH-吡嗪并[1′,2′:1,5]吡咯并[2,3-B]吲哚]-1,1′,4,4′-四酮; chetocin; Chaetocin A; (3S,3'S,5aR,5'aR,10bR,10'bR,11aS,11'aS)-2,2',3,3',5a,5'a,6,6'-Octahydro-3,3'-bis(hydroxymethyl)-2,2'-dimethyl-[10b,10'b(11H,11'H)-bi-3,11a-epidithio-11aH-pyrazino[1',2':1,5]pyrrolo[2,3-b]indole]-1,1',4,4'-tetrone; [10b,10'b(11H,11'H)-Bi-3,11a-epidithio-11aH-pyrazino[1',2':1,5]pyrrolo[2,3-b]indole]-1,1',4,4'-tetrone,2,2',3,3',5a,5'a,6,6'-octahydro-3,3'-bis(hydroxymethyl)-2,2'-dimethyl-,(3S,3'S,5aR,5'aR,10bR,10'bR,11aS,11'aS)-; HMTase Inhibitor II, Chaetocin; (3S,3'S,6R,6'R,14R,14'R,16S,16'S)-3,3'-bis(hydroxymethyl)-2,2'-dimethyl-2,2',3,3',6,6',7,7'-octahydro-1H,1'H-[14,14'-bi(3,11a-epidithiopyrazino[1',2':1,5]pyrrolo[2,3-b]indole)]-1,1',4,4'(15H,15'H)-tetrone; (3S,3'S)-3,3'-bis-hydroxymethyl-2,2'-dimethyl-(5at,10bt,5'at',10'bt')-2,3,5a,6,2',3',5'a,6'-octahydro-[10b,10'b]bi[3r,11ac-epidisulfano-pyrazino[1',2':1,5]pyrrolo[2,3-b]indolyl]-1,4,1',4'-tetraone; (+)-chaetocin A; (1S,1'S,3R,3'R,11R,11'R,14S,14'S)-14,14'-Bis(hydroxymethyl)-18,18'-dimethyl-3,3'-bi(15,16-dithia-10,12,18-triazapentacyclo[12.2.2.0.0.0]octadecane)-4,4',6,6',8,8'-hexaene-13,13',17,17'-tetrone
- 用途
- 毛壳素是真核细胞组蛋白甲基转移酶SU(VAR)3-9和G9a的特异性抑制剂，可改变细胞染色质结构，影响表观遗传学调控，改变重要基因表达，在肿瘤治疗方面有潜在临床价值；在制备预防和治疗糖尿病药物中，可纠正糖代谢紊乱，降低血糖，改善胰岛B细胞功能，改善胰岛素抵抗，增强免疫功能，降低血清总胆固醇、甘油三酯等，改善血流变，阻止或延缓动脉粥样硬化，用于防治糖尿病心血管病变。
